NRx Pharmaceuticals (NRXP) announced it has applied to Nasdaq to uplist the company’s securities to the Nasdaq Global Market. The company has advised NASDAQ that it currently has 15.7M outstanding shares of common stock, which will inform the calculation of the company’s market capitalization.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRXP:
- NRx Pharmaceuticals, HOPE sign term sheet for $27M in funding
- HOPE Therapeutics announces planned acquisition of Dura Medical
- NRx Pharmaceuticals, Hope announce planned acquisition of Kadima
- NRx Pharmaceuticals announces first section of NDA for NRX-100
- NRX Pharmaceuticals Strengthens Leadership with New CFO Appointment
Questions or Comments about the article? Write to editor@tipranks.com